Alpha Diagnostic International, Inc. (ADI) is excited to announce the availability of the Zika envelope protein antigen quantitative ELISA to facilitate the rapid development of Zika vaccines. This newly developed, first of its kind Zika envelope protein antigen ELISA is a simple, rapid (<4 hours.), and highly sensitive (<0.5 ng/ml) test to measure the Zika envelope protein in vaccine formulations. The non-quantitative reagents and tests that are currently available from various other suppliers were not optimized for performing quantitative assays, thereby making it very tedious and difficult to perform research aimed towards the development of Zika vaccines. Most Zika vaccines that are actively under development and testing are targeted towards the Zika envelope protein as the sole or major active component for the vaccine formulations.
For more information, please visit our website:
ADI had developed severy recombinant proteins, purified antibodies and antibody ELISA kits for related viruses West Nile virus, Japanese Encephalitis virus, Dengue virus, Chikungunya virus, etc. to assist reachers in vaccine development and triials as well as detection of virial proteins.